Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L15 pseudogene 5 (RPL15P5) is a non-functional genomic DNA sequence similar to the protein-coding RPL15 gene, which encodes a component of the 60S ribosomal subunit[1][2]. Like other processed pseudogenes, RPL15P5 does not produce a functional protein, has no known biological activity, and is not considered a therapeutic or druggable target[1][2][5]. Its presence is largely due to evolutionary duplication and loss of coding capacity, and it should not be confused with RPL15 or mitochondrial ribosomal protein L15, which are protein-coding and may have disease associations[1][2][4][5][6]. Note: The correct druggable gene in this family would be RPL15 (Ribosomal protein L15), not RPL15P5 (the pseudogene)[1][5]. If information on the actual protein-coding gene is required, please specify RPL15 or MRPL15.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L15 pseudogene 5 (RPL15P5).